State Street’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-84,811
| Closed | -$287K | – | 3767 |
|
|
2017
Q1 | $287K | Sell |
84,811
-425
| -0.5% | -$1.44K | ﹤0.01% | 3467 |
|
|
2016
Q4 | $445K | Sell |
85,236
-2,866
| -3% | -$15K | ﹤0.01% | 3407 |
|
|
2016
Q3 | $2.22M | Sell |
88,102
-11,005
| -11% | -$278K | ﹤0.01% | 2930 |
|
|
2016
Q2 | $2.45M | Buy |
99,107
+29,569
| +43% | +$731K | ﹤0.01% | 2946 |
|
|
2016
Q1 | $2.01M | Buy |
69,538
+4,278
| +7% | +$124K | ﹤0.01% | 3002 |
|
|
2015
Q4 | $2.42M | Buy |
65,260
+743
| +1% | +$27.6K | ﹤0.01% | 2918 |
|
|
2015
Q3 | $3.14M | Buy |
64,517
+22,458
| +53% | +$1.09M | ﹤0.01% | 2774 |
|
|
2015
Q2 | $2.9M | Buy |
+42,059
| New | +$2.9M | ﹤0.01% | 2911 |
|
|
2013
Q3 | – | Sell |
-595
| Closed | -$17K | – | 3645 |
|
|
2013
Q2 | $17K | Buy |
+595
| New | +$17K | ﹤0.01% | 3530 |
|